Efficacy and safety of AZD9056 200 mg once daily versus placebo in adult patients with active Crohn's disease - A randomized, pilot, double-blind, four week parallel-group, multicentre, phase II study
Study identifier:D8830C00002
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Efficacy and safety of AZD9056 200 mg once daily versus placebo in adult patients with active Crohn's disease - A randomized, pilot, double-blind, four week parallel-group, multicentre, phase II study
Medical condition
Rheumatoid Arthritis
Phase
Phase 2
Healthy volunteers
-
Study drug
-
Sex
-
Actual Enrollment
-
Study type
Interventional
Age
-
Date
Study Start Date: 01 Jan 2006
Primary Completion Date: -
Study Completion Date: -
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
